The University of Connecticut Technology Incubation Program (UConn TIP) is currently home to 33 tech-based startup companies.
By combining UConn’s research resources, facilities, and business support services with a network of experienced investors and entrepreneurs, TIP helps launch startups ready to transform their respective markets.
TIP has made significant headway in 2017. See below for a recap.
TIP STARTUPS RAISE $54+ MILLION IN FUNDING IN 2017
TIP companies have exceeded the stretch goal for funding in 2017. The tech startups have raised more than $54 million in company funding, exceeding the $45.3 million raised in 2016 and $19.2 million in 2015.
- TIP member Thetis Pharmaceuticals, which is funded by Connecticut Innovations was recently awarded a $2.3 million NIH grant. Find out more.
- Amastan Technologies, which graduated from the TIP, raised $13.85 million in new funding. Find out more.
JOHNSON & JOHNSON’S INNOVATION DIVISION SCOPES OUT UCONN’S INCUBATOR STARTUPS
TIP director Paul Parker said incubator companies are always on the hunt for outside financing and research partnerships. He noted that many TIP companies are working in an area of medical science that could be of interest to Johnson & Johnson.
INSIDE UCONN TIP: MAKING THE TECH OF TOMORROW, TODAY
Inside UConn TIP is a look into the University of Connecticut’s Technology Incubation Program. Discoveries made in UConn labs turn into the tech of tomorrow. In the podcast series, UConn graduate and Podstories Founder Ali Oshinskie shows how three companies are innovating in their fields.
- Listen to Podstories podcasts about UConn TIP startups
- Learn more about Podstories Founder Ali Oshinskie in our interview
Interested in learning more about the University of Connecticut Technology Incubation Program?
- Find out how the TIP is fostering innovative startups and enhancing economic development throughout Connecticut
- Read our interview with Shoreline Biome Co-Founder Thomas Jarvie: Biotech Startup Develops Innovative Sequencing Technique
- Read our interview with LamdaVision President Dr. Nicole Wagner: Biotech Startup Develops Innovative, Protein-Based Retinal Implant